CK Life Sciences Intl (Holdings) Inc
Melvin Toh serves as Vice President and Chief Scientific Officer at CK Life Sciences, where responsibilities include technology and product development with a focus on pharmaceuticals, medical devices/diagnostics, and healthcare services. Prior experience includes roles at Pfizer, such as Vice President of Pharmaceutical Development, Vice President of Clinical & Regulatory Affairs, Director of Clinical Pharmacology in Oncology Development, Medical Director at the Pfizer Clinical Research Unit in Singapore, and Regional Pharmacovigilance Manager. Earlier career experience includes serving as a Medical Monitor at Quintiles East Asia. Melvin Toh holds an MBBS degree in Medicine from the National University of Singapore and an MSc in Epidemiology from the University of London.
This person is not in any teams
This person is not in any offices
CK Life Sciences Intl (Holdings) Inc
CK Life Sciences Int'I., (Holdings) Inc. is a Hong Kong-based investment holding company principally engaged in the development and sales of healthcare products. The Company operates through three segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others. The Investment segment is engaged in the investment in financial and investment products.